Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nanobiotix (NBTX) Other Non-Current Liabilities (2019 - 2025)

Nanobiotix has reported Other Non-Current Liabilities over the past 7 years, most recently at $590170.1 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 27.84% year-over-year to $590170.1; the TTM value through Dec 2025 reached $590170.1, up 27.84%, while the annual FY2025 figure was $590170.1, 27.84% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $590170.1 at Nanobiotix, up from $542208.7 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $590170.1 in Q4 2025 and troughed at $266764.2 in Q2 2022.
  • A 5-year average of $412096.3 and a median of $376269.6 in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 51.53% in 2022 and later surged 39.47% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $363782.8 in 2021, then decreased by 24.28% to $275466.8 in 2022, then increased by 26.16% to $347528.6 in 2023, then soared by 32.83% to $461633.2 in 2024, then rose by 27.84% to $590170.1 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NBTX at $590170.1 in Q4 2025, $542208.7 in Q2 2025, and $461633.2 in Q4 2024.